골수증식 종양의 2017년 WHO 진단기준 주요 변경 사항의 이해
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장미애 | - |
dc.date.accessioned | 2021-08-11T13:23:47Z | - |
dc.date.available | 2021-08-11T13:23:47Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1738-9364 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6574 | - |
dc.description.abstract | The World Health Organization (WHO) Classification of Tumors of Haematopoietic and Lymphoid Tissues was recently published in a revised fourth edition. The categories of myeloproliferative neoplasms (MPNs) have not significantly changed since the 2008 fourth edition of the classification; however, newly discovered mutations including CALR and CSF3R and improved characterizations and standardizations of morphological features of some entities, particularly BCR-ABL1-negative MPNs, have impacted the diagnostic criteria of disease entities, increasing the reliability and reproducibility of diagnoses. The 2017 revised edition attempts to incorporate new clinical, prognostic, morphologic, and genetic data that have emerged since the last edition. This article reviews the major changes in the classification and their rationale for MPN classification within the revised 2017 WHO system. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한내과학회 | - |
dc.title | 골수증식 종양의 2017년 WHO 진단기준 주요 변경 사항의 이해 | - |
dc.title.alternative | Major Changes to the 2017 Revision of the World Health Organization Classification of Myeloproliferative Neoplasms | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 장미애 | - |
dc.identifier.bibliographicCitation | 대한내과학회지, v.93, no.4, pp.351 - 359 | - |
dc.relation.isPartOf | 대한내과학회지 | - |
dc.citation.title | 대한내과학회지 | - |
dc.citation.volume | 93 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 351 | - |
dc.citation.endPage | 359 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002371942 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Essential thrombocythemia | - |
dc.subject.keywordAuthor | Myeloproliferative disorders | - |
dc.subject.keywordAuthor | Polycythemia vera | - |
dc.subject.keywordAuthor | Primary myelofibrosis | - |
dc.subject.keywordAuthor | World Health Organization | - |
dc.subject.keywordAuthor | 본태혈소판증가증 | - |
dc.subject.keywordAuthor | 골수증식 종양 | - |
dc.subject.keywordAuthor | 진성적혈구증가증 | - |
dc.subject.keywordAuthor | 일차골수섬유증 | - |
dc.subject.keywordAuthor | 세계보건기구 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.